Biotie Therapies Corp. – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 12/31/15 FY 2015

Prospectuses and Registrations Filter

Securities registration termination

Amendment to registration of securities for employees

Removal from listing

Third party tender offer – amended

Third party tender offer – amended

Ownership Filter

ACORDA THERAP.NEW DL-001

ACORDA THERAP.NEW DL-001

Vivo Capital VIII, LLC

Orbimed Advisors LLC

Baupost Group LLC/Ma

News Filter

Acorda Therapeutics, Inc. Gains Title to All Shares in Biotie Therapies Corp. and the Shares Will Delist From NASDAQ Helsinki

The Arbitral Tribunal Has Confirmed Acorda Therapeutics, Inc.'s Redemption Right Regarding the Shares in Biotie Therapies Corp. and Public Trading in the Shares Has Been Terminated

Biotie: BTT1023 Receives Orphan Drug Designation in the United States

The Listing Committee of NASDAQ Helsinki Has Resolved to Delist the Shares of Biotie Therapies Corp

Applies for Delisting of Its Shares From NASDAQ Helsinki

Proxies

No filings in this category.

Other Filter

Confidential treatment order

Confidential treatment order

Letter from the SEC

Confidential treatment order

Approval for listing by National Association of Securities Dealers